Top Markets
Coin of the day
MDxHealth S.A. MDxHealth S.A.

MDxHealth S.A.

MDXH
Rangering i aksjer #21732
MDxHealth S.A. is a commercial-stage precision diagnostics company that... MDxHealth S.A. is a commercial-stage precision diagnostics company that delivers urological solutions across the United States, the Netherlands, Belgium, Spain, Poland, Italy, the rest of the European Union, and other international markets. They offer innovative genomic testing solutions for prostate cancer, notably the non-invasive SelectMDx urine test and the epigenetic ConfirmMDx test. These advanced tools assist physicians in identifying clinically significant prostate cancer, thus minimizing the need for invasive procedures and their associated complications. Founded in 2003 as OncoMethylome Sciences SA, the company adopted its current name, MDxHealth SA, in October 2010 and is headquartered in Herstal, Belgium.
Aksjekurs
$3.58
Sist synkronisert: 2023-12-15
Markedsverdi
$101.57M
Endring (1 dag)
3.79%
Endring (1 år)
0.00%
Land
BE
Handel MDxHealth S.A. (MDXH)

Kategori

P/B-forhold for MDxHealth S.A. (MDXH)
P/B-forhold per 2026 TTM: 0
Ifølge MDxHealth S.A. sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/B-forhold på 0.
P/B-historikk for MDxHealth S.A. fra 2026 til 2026
P/B-forhold ved hvert års slutt
År P/B-forhold Endre
Ikke nok data for de angitte datoene.
P/B-forhold for lignende selskaper eller konkurrenter
Selskap P/B-forhold Forskjell i P/B-forhold Land
4.1431 -
US
2.7156 -
US
- -
CN
24.3791 -
US
5.9029 -
US